Entrectinib in locally advanced/metastatic ROS1 and NTRK fusion-positive non-small cell lung cancer (NSCLC): Updated integrated analysis of STARTRK-2, STARTRK-1 and ALKA-372-001
de Braud, F., Siena, S., Barlesi, F., Drilon, A., Simmons, B., Huang, X., Osborne, S., Doebele, R.C.Volume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz420.003
Date:
November, 2019
File:
PDF, 87 KB
english, 2019